预防性脑脊液引流预防胸主动脉腔内修复术后脊髓缺血相关性的系统综述与荟萃分析
该系统综述与荟萃分析共纳入34项研究、3561例患者,比较预防性脑脊液引流(CSFD)与非CSFD在胸主动脉腔内修复(TEVAR)术后预防脊髓缺血(SCI)的相关性。结果显示,主动脉瘤患者TEVAR术后SCI发生率高于主动脉夹层患者;对胸腹主动脉瘤患者,常规预防性CSFD较选择性CSFD与更低的术后SCI率相关。
要点
- 预防性CSFD下,主动脉夹层患者TEVAR术后SCI合并事件率为1.80%,显著低于主动脉瘤组的5.73%。
- 主动脉夹层患者中,预防性CSFD与非CSFD的TEVAR术后SCI率无显著差异(P = .51)。
- 胸腹主动脉瘤患者中,常规预防性CSFD的TEVAR术后SCI率显著低于选择性预防性CSFD(P = .04)。
核心结论
- TEVAR术后SCI在主动脉瘤患者中比在主动脉夹层患者中更常见。
- 对胸腹主动脉瘤患者,常规预防性CSFD较选择性CSFD与更低的术后SCI率相关。
- 对孤立性胸主动脉瘤或主动脉夹层患者,常规预防性CSFD与SCI率之间无显著关联。
研究设计与样本
- 该系统综述与荟萃分析系统检索了MEDLINE、Embase和Cochrane数据库截至2020年4月1日报告的所有相关研究。
- 共纳入34项研究、3561例患者,其中2671例为胸主动脉瘤或胸腹主动脉瘤,890例为B型主动脉夹层。
- 比较了常规预防性CSFD与选择性CSFD或无CSFD策略下,主动脉夹层、孤立性胸主动脉瘤或胸腹主动脉瘤患者TEVAR术后SCI率。
- 进行了亚组分析,评估不同主动脉病理(包括主动脉夹层与胸部动脉瘤)与TEVAR术后SCI率的关系。
- 数据以合并事件率(ER)和95%置信区间(CI)呈现。
主要发现
- 预防性CSFD下TEVAR术后总体SCI率:主动脉夹层组ER 1.80%(95% CI 0.88%-2.72%),显著低于主动脉瘤组ER 5.73%(95% CI 4.20%-7.27%)(P < .0001)。
- 主动脉夹层患者中,预防性CSFD与非CSFD的TEVAR术后SCI率无显著差异(P = .51)。
- 主动脉瘤患者中,常规预防性CSFD与选择性预防性CSFD的TEVAR术后SCI率无显著关联(P = .76);主动脉夹层患者中两者亦无显著关联(P = .70)。
- 无CSFD时,主动脉瘤(包括孤立性胸主动脉瘤和胸腹主动脉瘤)TEVAR术后SCI率ER 3.49%(95% CI 0.23%-6.76%),与主动脉夹层ER 3.20%(95% CI 0.00%-7.20%)无显著差异(P = .91)。
- 胸腹主动脉瘤患者中,常规预防性CSFD的TEVAR术后SCI率显著低于选择性预防性CSFD(P = .04)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We conducted a systemic review and meta-analysis to compare the association between prophylactic cerebrospinal fluid drainage (CSFD) vs non-CSFD in preventing spinal cord ischemia (SCI) after thoracic endovascular aortic repair (TEVAR) for aneurysm and dissection. METHODS: The MEDLINE, Embase, and Cochrane databases were systematically searched to identify all relevant studies reported before April 1, 2020. A systematic review and meta-analysis were performed. We assessed the association between CSFD strategies, including routine CSFD vs selective CSFD or no CSFD, and the SCI rates after TEVAR for patients with aortic dissection (AD), solitary thoracic aortic aneurysm (TAA), or thoracoabdominal aortic aneurysm (TAAA). Subgroup analyses were conducted to assess the association between different aortic pathologies, including AD and thoracic aneurysms, and SCI rates after TEVAR with and without prophylactic CSFD. The data are presented as the pooled event rates (ERs) and 95% confidence intervals (CIs). RESULTS: A total of 34 studies of 3561 patients (2671 with TAA or TAAA and 890 with type B AD) were included in the present analysis. The data are presented as the pooled ERs and 95% CIs. The overall SCI rate for patients who had undergone TEVAR with prophylactic CSFD for AD (ER, 1.80%; 95% CI, 0.88%-2.72%) was significantly lower than that for the aortic aneurysm group (ER, 5.73%; 95% CI, 4.20%-7.27%; P < .0001). The SCI rate after TEVAR with prophylactic CSFD was not significantly different from that without CSFD for AD (P = .51). No association was found between the rates of SCI after TEVAR with routine prophylactic CSFD vs selective prophylactic CSFD for aortic aneurysms (P = .76) and AD (P = .70). The SCI rate after TEVAR without CSFD for aortic aneurysms, including isolated TAA and TAAA (ER, 3.49%; 95% CI, 0.23%-6.76%) was not significantly different from that for AD (ER, 3.20%; 95% CI, 0.00%-7.20%; P = .91). For the patients with TAAAs, the rate of SCI after TEVAR with routine prophylactic CSFD was significantly lower than that with selective prophylactic CSFD (P = .04). CONCLUSIONS: Our systematic review and meta-analysis has shown that SCI occurs more often after TEVAR for aortic aneurysms than for AD. Routine prophylactic CSFD, compared with selective CSFD, was associated with a lower rate of postoperative SCI after TEVAR for TAAAs. No significant association was found between the SCI rate and routine prophylactic CSFD for patients undergoing TEVAR for isolated TAA or AD.
引用
- Zhang Z, Zhou Y, Lin S, et al. Systematic review and meta-analysis of association of prophylactic cerebrospinal fluid drainage in preventing spinal cord ischemia after thoracic endovascular aortic repair. J Vasc Surg. 2021. PMID: 34793925. doi:10.1016/j.jvs.2021.10.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。